tiprankstipranks
Trending News
More News >
Town Health International Medical Group Ltd. (HK:3886)
:3886
Hong Kong Market

Town Health International Medical Group Ltd. (3886) AI Stock Analysis

Compare
1 Followers

Top Page

HK:3886

Town Health International Medical Group Ltd.

(3886)

Select Model
Select Model
Select Model
Neutral 52 (OpenAI - 5.2)
Rating:52Neutral
Price Target:
HK$0.24
▼(-4.00% Downside)
The stock score is primarily impacted by financial performance challenges, particularly in profitability and cash flow management. Technical indicators suggest bearish momentum, and valuation is affected by a negative P/E ratio despite a high dividend yield.
Positive Factors
Strong balance sheet liquidity
A strong equity base and ample cash reserves provide durable financial stability, enabling Town Health to fund operations, absorb shocks, and invest in capacity or partnerships without immediate reliance on volatile external financing. This supports long-term strategic flexibility.
Diversified revenue streams
Multiple revenue streams (outpatient care, hospital management, telemedicine, insurer and corporate programs) reduce single-market dependence. Structurally, this diversification supports steadier cash generation and cross-selling opportunities as healthcare demand and digital care adoption grow.
Leading local market position and scale
As a leading Hong Kong healthcare provider with over 1,100 staff, Town Health benefits from scale, brand recognition, and network effects that aid patient acquisition and partnerships. This market position is a durable competitive advantage for service expansion and negotiating hospital/insurer deals.
Negative Factors
Sustained profitability weakness
Recurring negative net income indicates structural profitability issues that can erode reserves and constrain reinvestment. Persistent losses suggest pricing, cost structure, or utilization challenges that must be fixed to restore sustainable earnings and free cash flow generation.
Inconsistent cash generation
Fluctuating free cash flow and operating cash shortfalls versus accounting loss point to liquidity pressure and weaker cash conversion. Over months this limits capital investments, dividend sustainability and forces reliance on reserves or debt, raising financing risk for growth initiatives.
Margin pressure and rising leverage
Declining gross margins combined with a rising debt-to-equity trend signal margin compression and higher leverage. Structurally, this reduces operational resilience and increases fixed obligations, limiting the firm's ability to absorb cost shocks or finance expansion without improving profitability.

Town Health International Medical Group Ltd. (3886) vs. iShares MSCI Hong Kong ETF (EWH)

Town Health International Medical Group Ltd. Business Overview & Revenue Model

Company DescriptionTown Health International Medical Group Limited, an investment holding company, invests in, manages, and provides healthcare and related services in the People's Republic of China and Hong Kong. The company operates through Hong Kong Medical Services; Hong Kong Managed Medical Network Business; Mainland Hospital Management and Medical Services; and Others segments. It provides cross-border healthcare, managed care business, medical diagnostic, health check, and ophthalmic medical services; and third-party medical network administrator services. The company also offers medical healthcare and dental consultation, property investment, and medical tourism services. In addition, it trades in listed securities; leases properties; offers beauty and cosmetic medical, laboratory, hospital management, eye care, and business and corporate advisory services. Further, the company engages in the trading of medical equipment and medicines. As of December 31, 2021, it had 454 healthcare service points covering multiple practices, including 259 general practice service points, 75 specialist service points, 23 dental service points, and 97 auxiliary service points. The company was formerly known as Town Health International Investments Limited and changed its name to Town Health International Medical Group Limited in March 2014. Town Health International Medical Group Limited was founded in 1989 and is headquartered in Shatin, Hong Kong.
How the Company Makes MoneyTown Health International Medical Group Ltd. generates revenue through several key streams. The primary source of income comes from outpatient services, where the company charges patients for consultations, diagnostic tests, and treatment plans. Additionally, Town Health earns revenue from its partnerships with hospitals and clinics, providing management services and sharing in the profits generated from patient care. Telemedicine services also contribute to revenue by enabling consultations and follow-ups via digital platforms, appealing to a broader patient base. Moreover, the company may receive income from health insurance reimbursements, as well as from corporate health programs and wellness initiatives offered to businesses. Strategic alliances with healthcare providers and insurers further enhance its market reach and profitability.

Town Health International Medical Group Ltd. Financial Statement Overview

Summary
The company shows moderate revenue growth but faces profitability challenges with negative net income. The balance sheet is strong with high equity and liquidity, though cash flow management is concerning due to inconsistent free cash flow.
Income Statement
60
Neutral
The revenue has shown moderate growth from 2020 to 2024, with a notable dip in gross profit margin from 2023 to 2024. The company has experienced negative net income in the recent years, indicating profitability challenges. EBIT and EBITDA margins are also under pressure, suggesting operational inefficiencies.
Balance Sheet
70
Positive
The company maintains a strong equity base with a favorable equity ratio. However, the debt-to-equity ratio has increased slightly over the years, signaling rising leverage. Despite this, the company has ample cash reserves, enhancing financial stability.
Cash Flow
50
Neutral
There is a lack of consistent positive free cash flow growth with significant fluctuations over the years. The operating cash flow has been insufficient to cover net income, indicating potential liquidity issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.82B1.83B1.83B1.54B1.48B1.07B
Gross Profit468.01M487.39M501.95M414.45M471.26M284.58M
EBITDA140.81M160.68M53.50M237.57M219.79M-97.78M
Net Income-143.30M-203.70M-194.21M15.29M22.01M-281.04M
Balance Sheet
Total Assets4.10B4.13B4.50B4.75B4.73B4.58B
Cash, Cash Equivalents and Short-Term Investments1.38B1.40B1.20B1.35B1.89B1.82B
Total Debt262.47M357.62M456.94M475.02M117.97M139.88M
Total Liabilities666.65M746.56M881.82M896.09M504.94M456.51M
Stockholders Equity3.01B2.98B3.24B3.49B3.86B3.81B
Cash Flow
Free Cash Flow172.04M206.11M229.79M-5.46M151.00M3.75M
Operating Cash Flow213.08M244.83M247.53M31.73M170.95M39.05M
Investing Cash Flow291.15M164.29M-20.95M587.77M-261.67M-742.86M
Financing Cash Flow-182.29M-235.72M-151.07M-518.45M-90.80M-93.68M

Town Health International Medical Group Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.25
Price Trends
50DMA
0.25
Negative
100DMA
0.26
Negative
200DMA
0.25
Negative
Market Momentum
MACD
>-0.01
Negative
RSI
43.11
Neutral
STOCH
65.22
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3886, the sentiment is Negative. The current price of 0.25 is above the 20-day moving average (MA) of 0.24, above the 50-day MA of 0.25, and below the 200-day MA of 0.25, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.11 is Neutral, neither overbought nor oversold. The STOCH value of 65.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:3886.

Town Health International Medical Group Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
HK$568.47M6.895.33%9.14%0.47%50.46%
66
Neutral
HK$1.37B4.7120.47%4.37%-3.56%-17.45%
56
Neutral
HK$710.32M4.8930.40%2.30%
52
Neutral
HK$1.63B-11.32-4.66%0.49%-0.55%45.36%
52
Neutral
HK$1.03B39.671.27%-4.30%13.83%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
45
Neutral
HK$1.26B-10.19-3.59%2.02%-4.09%-1242.31%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3886
Town Health International Medical Group Ltd.
0.24
-0.05
-16.67%
HK:9960
Kindstar Globalgene Technology, Inc.
1.21
0.06
5.22%
HK:1526
Rici Healthcare Holdings Ltd.
0.86
-0.37
-30.08%
HK:3689
Guangdong Kanghua Healthcare Co., Ltd. Class H
1.70
-0.34
-16.67%
HK:3869
Hospital Corporation of China Ltd
5.14
-1.65
-24.30%
HK:6639
Arrail Group Ltd.
1.83
-0.57
-23.79%

Town Health International Medical Group Ltd. Corporate Events

Town Health Tightens Nomination Committee Rules to Bolster Board Governance
Dec 31, 2025

Town Health International Medical Group Limited has updated the terms of reference for its nomination committee, effective 1 January 2026, to reinforce governance over board appointments and composition. The revised framework formalises the committee’s responsibility for fair and transparent director nominations, requires a majority of independent non-executive directors and at least one member of a different gender on the committee, and empowers it to review board structure, assess director independence, oversee succession planning for key leadership roles, and support regular board performance evaluations, thereby strengthening the company’s corporate governance practices and board oversight.

The most recent analyst rating on (HK:3886) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Town Health International Medical Group Ltd. stock, see the HK:3886 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 06, 2025